Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Radaelli

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Journal of Neurology|November 3, 2023
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster doseMassimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Journal of Neurology|March 18, 2018
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT studyRoberta Lanzillo, Luca Prosperini, Claudio Gasperini, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre studyDiana Ferraro, Pietro Annovazzi, Marcello Moccia, et al.
Journal of Neurology|April 4, 2022
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Journal of Neurology|November 3, 2023
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster doseMassimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Journal of Neurology|March 18, 2018
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT studyRoberta Lanzillo, Luca Prosperini, Claudio Gasperini, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre studyDiana Ferraro, Pietro Annovazzi, Marcello Moccia, et al.
Journal of Neurology|April 4, 2022
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Pageof 9